Barthel, Henryk
Leipzig University
17 papers on CoChatORCID 0000-0002-9322-9167
Most cited papers
- Verified
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 1,610
- Verified
Prevalence of Amyloid PET Positivity in Dementia Syndromes: A Meta-analysis
Ossenkoppele, R., Jansen, W. J., Rabinovici, G. D., Knol, D. L., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Visser, P. J., Verfaillie, S. C. J., Zwan, M. D., et al. (2015) · JAMA
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 677
- Verified
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Sabri, O., Sabbagh, M. N., Seibyl, J., Barthel, H., Akatsu, H., Ouchi, Y., Senda, K., Murayama, S., Ishii, K., Takao, M., et al. (2015) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 602
- Verified
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., et al. (2020) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 526
- Verified
JuSpace : A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps
Dukart, J., Holiga, S., Rullmann, M., Lanzenberger, R., Hawkins, P. C. T., Mehta, M. A., Hesse, S., Barthel, H., Sabri, O., Jech, R., et al. (2021) · Human Brain Mapping
Functional Brain Connectivity StudiesAdvanced MRI Techniques and Applications
Cited by 347
- Verified
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Amyloid Biomarker Study Group, Aarsland, D., Alcolea, D., Altomare, D., et al. (2022) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 290
- Verified
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder
Hesse, S., Müller, U., Lincke, T., Barthel, H., Villmann, T., Angermeyer, M. C., Sabri, O., & Stengler-Wenzke, K. (2005) · Psychiatry Research: Neuroimaging
Obsessive-Compulsive Spectrum DisordersNeurotransmitter Receptor Influence on Behavior
Cited by 155
- Verified
Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging
Kaller, S., Rullmann, M., Patt, M., Becker, G.-A., Luthardt, J., Girbardt, J., Meyer, P. M., Werner, P., Barthel, H., Bresch, A., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging
Neurotransmitter Receptor Influence on BehaviorMedical Imaging Techniques and Applications
Cited by 152
- Verified
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies
Dukart, J., Mueller, K., Horstmann, A., Vogt, B., Frisch, S., Barthel, H., Becker, G., Möller, H. E., Villringer, A., Sabri, O., et al. (2010) · NeuroImage
Dementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications
Cited by 134
- Verified
Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases
Daerr, S., Brendel, M., Zach, C., Mille, E., Schilling, D., Zacherl, M. J., Bürger, K., Danek, A., Pogarell, O., Schildan, A., et al. (2017) · NeuroImage: Clinical
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 124
- Verified
PET/MR in Dementia and Other Neurodegenerative Diseases
Barthel, H., Schroeter, M. L., Hoffmann, K.-T., & Sabri, O. (2015) · Seminars in Nuclear Medicine
Dementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications
Cited by 123
- Verified
Serum neurofilament light chain in behavioral variant frontotemporal dementia
Steinacker, P., Anderl-Straub, S., Diehl-Schmid, J., Semler, E., Uttner, I., von Arnim, C. A. F., Barthel, H., Danek, A., Fassbender, K., Fliessbach, K., et al. (2018) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 116
- Verified
Comparison of 18F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL® approaches: Validation against histopathology
Doré, V., Bullich, S., Rowe, C. C., Bourgeat, P., Konate, S., Sabri, O., Stephens, A. W., Barthel, H., Fripp, J., Masters, C. L., et al. (2019) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 93
- Verified
Early detection of amyloid load using 18F-florbetaben PET
Bullich, S., Roé-Vellvé, N., Marquié, M., Landau, S. M., Barthel, H., Villemagne, V. L., Sanabria, Á., Tartari, J. P., Sotolongo-Grau, O., Doré, V., et al. (2021) · Alzheimer's Research & Therapy
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 71
- Verified
Damaged Neocortical Perineuronal Nets Due to Experimental Focal Cerebral Ischemia in Mice, Rats and Sheep
Härtig, W., Mages, B., Aleithe, S., Nitzsche, B., Altmann, S., Barthel, H., Krueger, M., & Michalski, D. (2017) · Frontiers in Integrative Neuroscience
Barrier Structure and Function StudiesProteoglycans and glycosaminoglycans research
Cited by 53
- Verified
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
Finze, A., Biechele, G., Rauchmann, B.-S., Franzmeier, N., Palleis, C., Katzdobler, S., Weidinger, E., Guersel, S., Schuster, S., Harris, S., et al. (2023) · Molecular Psychiatry
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 40
- Verified
Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
Rullmann, M., Brendel, M., Schroeter, M. L., Saur, D., Levin, J., Perneczky, R. G., Tiepolt, S., Patt, M., Mueller, A., Villemagne, V. L., et al. (2022) · Biomolecules
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free